Genetic Technologies
In Brief This Week: Centogene, Novacyt, T2 Biosystems, Inotiv, Oxford Nanopore, More
News items for the week of July 11, 2022.
Genetic Technologies Lab Gets Regulatory Approvals in US, Australia
The lab has received NATA accreditation and CLIA certification, enabling the launch of the company's multi-disease risk assessment test in Australia and the US.
In Brief This Week: Pathogenomix, Uniogen, Genetic Technologies, DnaNudge, Gravity Diagnostics, More
News items for the week of Jan. 17, 2022.
Genetic Technologies, WashU Team up to Study Breast Cancer Risk in Woman of African Descent
The Australian company is working with the Institute for Public Health in St. Louis to expand the predictive capability of its GeneType breast cancer risk test.
Genetic Technologies Fiscal Year 2021 Revenues Soar on COVID-19 Test Alliance
Genetic Technologies recently signed an agreement to commercialize its test for assessing a COVID-19 patient's risk of severe disease in the US with Infinity Biologix.
May 26, 2020
Genetic Technologies Prices $8M Public Offering
Apr 20, 2020
Genetic Technologies Prices $1.4M Direct Offering
Apr 1, 2020
Genetic Technologies Inks Deals to Raise A$1.8M
Jun 19, 2018